Forest Baskett's Net Worth

$3.6 Billion

Who is Forest Baskett?

Forest Baskett has an estimated net worth of $3.6 Billion. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., Cloudflare, Inc., Desktop Metal, Inc., RHYTHM PHARMACEUTICALS, INC., Dermira, Inc., OPOWER, INC., Cascadian Therapeutics, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Echo Global Logistics, Inc., Arcellx, Inc., FUSION-IO, INC., MULESOFT, INC, ARYx Therapeutics, Inc., PEPLIN INC, HYPERION THERAPEUTICS INC, TriVascular Technologies, Inc., INNERWORKINGS INC, Robinhood Markets, Inc., Elastic N.V., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., Verona Pharma plc, SUPERNUS PHARMACEUTICALS INC, CHANNELADVISOR CORP, BuzzFeed, Inc., Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., Groupon, Inc., AVEO PHARMACEUTICALS, INC., Zosano Pharma Corp, Sprout Social, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Clovis Oncology, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, AMICUS THERAPEUTICS INC, IonQ, Inc., BOX INC, Coursera, Inc., Nightstar Therapeutics plc, Tintri, Inc., Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Reneo Pharmaceuticals, Inc., TREVENA INC, GENOCEA BIOSCIENCES, INC., Metacrine, Inc., PhaseBio Pharmaceuticals Inc, Inozyme Pharma, Inc., Millendo Therapeutics, Inc., TESARO, Inc., Eargo, Inc., PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., Galera Therapeutics, Inc., Savara Inc, Trevi Therapeutics, Inc., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., Annexon, Inc., SYNLOGIC, INC., Epizyme, Inc., SUNESIS PHARMACEUTICALS INC, MINERVA SURGICAL INC, Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Roka BioScience, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., IMARA Inc., Marker Therapeutics, Inc., Casper Sleep Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., ZeroFox Holdings, Inc., Tableau Software Inc, Senti Biosciences, Inc.\, Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, ATHEROS COMMUNICATIONS INC, XOOM Corp, Liquidia Technologies Inc, AUDIENCE INC, INTERLEUKIN GENETICS INC, HEMOSENSE INC, and Korro Bio, Inc..

SEC CIK

Forest Baskett's CIK is 0001277631

Past Insider Trading and Trends

2018 was Forest Baskett's most active year for acquiring shares with 75 total transactions. Forest Baskett's most active month to acquire stocks was the month of May. 2020 was Forest Baskett's most active year for disposing of shares, totalling 85 transactions. Forest Baskett's most active month to dispose stocks was the month of May. 2022 saw Forest Baskett paying a total of $146,449,993.20 for 14,474,870 shares, this is the most they've acquired in one year. In 2019 Forest Baskett cashed out on 145,573,724 shares for a total of $954,668,588.20, their largest year based on trade value.